Company:  GLYCOMIMETICS INC (GLYC)
Form Type:  4
Filing Date:  1/24/2020 
CIK:  0001253689 
Address:  9708 MEDICAL CENTER DRIVE 
City, State, Zip:  ROCKVILLE, Maryland 20850 
Telephone:  240-243-1201 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$3.77  
Change: 
-0.20 (-5.04%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$163.47M
Trade GLYC now with 

© 2020  
Description of Business
We are a clinical stage biotechnology company focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are small molecules that mimic the structure of carbohydrates involved in important biological processes. Using our expertise in carbohydrate chemistry and knowledge of carbohydrate biology, we are developing a pipeline of proprietary glycomimetics designed to inhibit disease-related functions of carbohydrates, such as the roles they play in inflammation, cancer and infection. We believe this represents an innovative approach to drug discovery to treat a wide range of diseases. Our proprietary glycomimetics platform is based on our expertise in carbohydrate chemistry and our understanding of the role carbohydrates play in key biological processes.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES